№8 (261) / 2013

V.V. Fomin
Opening Remarks
V.F. Semiglazov, V.V. Semiglazov
FOUR ASPECTS OF ADJUVANT TARGETED THERAPY OF HER2-POSITIVE BREAST CANCER 		10-14
A.A. Moiseyev
ROLE OF PHARMACOGENETICS IN INDIVIDUALIZING OF ANTICANCER CHEMOTHERAPY 		15-20
I.S.Romanov, L.P.Yakovleva
ISSUES OF TREATMENT OF ORAL CANCER 		21-25
R.I. Vabishchevich, Yu.A. Alekseeva
FEATURES OF COURSE OF VIRAL HEPATITIS IN PATIENTS WITH ONCOHEMATOLOGICAL DISEASES 		26-30
M .E. Abramov
ASPECTS OF USE OF PEGFILGRASTIM FOR THE CHEMOTHERAPY IN PATIENTS WITH SOLID TUMORS 		31-34
V.F.Semiglazov, G.A.Dashyan, T.Yu.Semiglazova, R. M. Paltuyev, K.Yu.Zernov, K.D.Penkov, I.A.Grechukhina, V. V. Semiglazov
THE ROLE OF IMMUNOCONJUGATES IN TARGETED THERAPY OF MALIGNAT TUMORS 		35-38
A.S. Tyulyandina
PRESENT AND FUTURE OF TARGETED THERAPY AS FIRST-LINE TREATMENT OF OVARIAN CANCER 		39-42
L.G.Zhukova
NEW POTENTIALS FOR THE THERAPY OF PATIENTS WITH METASTATIC BREAST CANCER PREVIOUSLY TREATED WITH ANTHRACYCLINE- AND TAXANE-BASED CHEMOTHERAPY: LITERATURE REVIEW AND CASE REPORT 		43-49
V.A. Tchernyaev
HORMONE THERAPY OF PROSTATE CANCER 		50-54
S.A. Volkov
CANCER-ASSOCIATED ANEMIA: CURRENT STATE OF PROBLEM AND THE ROLE OF INTRAVENOUS IRON SUPPLEMENTS 		56-58
N.N. Semenov
THE USE OF BISPHOSPHONATES FOR THE PREVENTION OF BONE METASTASES IN BREAST CANCER PATIENTS 		59-61
E.V. Bakhidze
COMBINATION THERAPY OF CERVICAL INTRAEPITHELIAL NEOPLASIA USING DRUG NEOVIR 		62-65
D.R. Naskhletashvili, T.M. Sharabura
EXPERIENCE OF USE THE NEW DOSAGE FORM OF THE TEMOZOLOMIDE: EXPANDING THE TREATMENT OPTIONS 		66-70
Z.G. Kadagidze, E.G. Slavina, M.E. Abramov, G.V. Vyshinskaya, A.D. Darenskaya
NEW IMMUNOMODULATOR REFNOT IN THE TREATMENT OF ONCOLOGICAL PATIENTS 		71-74
M.I. Sekacheva
CONVERSION AND NEOADJUVANT THERAPY OF COLORECTAL LIVER METASTASES 		75-79

Бионика Медиа